AmoyDx® NGS Panels: Decentralized, Fast, and Reliable
The AmoyDx® Next Generation Sequencing (NGS) portfolio empowers decentralized precision oncology with sensitive and practical panels for solid tumors and hematologic cancers, validated for clinical sample conditions.